Trials / Terminated
TerminatedNCT01078987
Plasmapheresis for Nephrogenic Fibrosing Dermopathy (NFD)/Nephrogenic Systemic Fibrosis (NSF)
Use of Plasmapheresis for Nephrogenic Fibrosing Dermopathy (NFD)/Nephrogenic Systemic Fibrosis (NSF) and Understanding Its Etiology
- Status
- Terminated
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- Loma Linda University · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate the pathophysiology of nephrogenic fibrosing dermopathy (NFD)/nephrogenic systemic fibrosis (NSF).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Plasmapheresis | A course of 5 daily treatments of plasma exchange (plasmapheresis) for one to three courses |
Timeline
- Start date
- 2002-02-01
- Primary completion
- 2012-03-01
- Completion
- 2012-03-01
- First posted
- 2010-03-02
- Last updated
- 2014-11-21
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01078987. Inclusion in this directory is not an endorsement.